Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma

Hepatology Research

Volumn 45, Issue 6, 2015, Pages 663-666

  Arai, Hirotaka ^a   Abe, Takehiko ^a   Takayama, Hisashi ^a   Toyoda, Mitsuo ^a   Ueno, Takashi ^a   Kakizaki, Satoru ^b   Sato, Ken ^b  

^a MAEBASHI RED CROSS HOSPITAL   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Balloon occluded transcatheter arterial chemoembolization; Hepatocellular carcinoma; Miriplatin

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GELATIN; MIRIPLATIN;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY CATHETERIZATION; ARTICLE; ASCITES; BALLOON CATHETERIZATION; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; HYPERBILIRUBINEMIA; LEUKOPENIA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROCATHETER; MIDDLE AGED; OCCLUSION BALLOON CATHETER; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; THROMBOCYTOPENIA; UPREGULATION; VERY ELDERLY;

EID: 84930250500     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12403     Document Type: Article

References (10)

1. Miyayama S, Matsui O, Yamashiro M etal. Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 2007; 18: 365-376.
2. Irie T, Kuramochi M, Takahashi N. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol 2013; 36: 706-713.
3. Irie T, Kuramochi M, Takahashi N. Improved accumulation of lipiodol under balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma: measurement of blood pressure at the embolized artery before and after balloon inflation. Jpn J Intervent Radiol 2011; 26: 49-54. (In Japanese.)
4. Okusaka T, Okada S, Nakanishi T etal. Phase?trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs 2004; 22: 169-176.
5. Imai N, Ikeda K, Kawamura Y etal. Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. Jpn J Clin Oncol 2012; 42: 175-182.
6. Okabe K, Beppu T, Haraoka K etal. Safety and short-term therapeutic effects of miriplatin-lipiodol suspension in transarterial chemoembolization (TACE) for hepatocellular carcinoma. Anticancer Res 2011; 31: 2983-2988.
7. The Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan. Report 13. Kanzo 1999; 40: 288-300.
8. The Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan. Report 14. Kanzo 2000; 41: 799-811.
9. The Liver Cancer Study Group of Japan. The fifth supplementary edition of General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2009.
10. The Japan Clinical Oncology Group (JCOG)/Japan Society of Clinical Oncology (JSCO). The Japanese translation of the Common Terminology Criteria for Adverse Events version 4.0. 2010.